External Suture‐Retention Device Versus Manual Compression for Venous Access‐Site Closure Post‐Ablation: The LockeT II Study
Journal of Cardiovascular Electrophysiology · 2026-08 · 37 (8) · 1723-1730
DOI: 10.1111/jce.70369 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 15.06.2026. Verfasst von Aashish Katapadi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Kansas City Heart Rhythm Institute, Overland Park, Kansas, USA. Hauptthemen laut MEDLINE: Catheter Ablation, Hemostatic Techniques, Suture Techniques, Vascular Closure Devices. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
The LockeT external suture retention device addresses the shortcomings of manual compression (MC), and other vascular closure devices—namely, prolonged immobilization, resource utilization, and costs.
Objective
In this study, we compare the safety and effectiveness of LockeT to that of MC.
Methods
We performed a prospective, single‐center study of patients (N) undergoing atrial fibrillation ablation, randomized 1:1 to MC or LockeT. Each vascular access site (n) was included for analysis. Assessments included hemostasis at two hours (HA2H), time to ambulation (TTA), time to (TTD) and same‐day discharge (SDD), groin complications, and a patient comfort assessment. Cost analysis was also performed.
Results
Patients were randomized to MC ( N = 49; n = 98) or LockeT ( N = 52; n = 102). Procedural times (119 [IQR 91−155] vs. 106 [IQR 84−127], p = 0.104) and maximum sheath size (8.5 [IQR 8.5−11] vs. 8.5 [IQR 8.5−11], p = 0.730) were no different. Neither HA2H (95.5% vs. 99%, p = 0.129) nor SDD rates (23.5% vs. 36.0%, p = 0.06) differed. However, TTA was significantly less (5.1 [IQR 3.9−6.5] vs. 4.4 [IQR 3.4−5.3], p = 0.017) in those with LockeT. In patients with SSD, the TTD was significantly shorter (6.0 [IQR 4.8−6.5] vs. 4.6 [IQR 4.3−4.9], p < 0.001). The cumulative complications were also significantly less (11.2% vs. 2.9%, p < 0.001) with LockeT.
Conclusion
The LockeT is associated with lower TTA, without major complications, and with effective hemostasis. It also limits post‐procedural time for groin management. However, further evaluation of the device is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Kansas City Heart Rhythm Institute, Overland Park, Kansas, USA.
- HCA Midwest, Kansas City, Kansas, USA.
- University of Texas Rio Grande Valley, Edinburg, Texas, USA.
- Catheter Precision, Fort Mills, South Carolina, USA.
- Texas Cardiac Arrhythmia Institute, Austin, Texas, USA.
- Montefiore Medical Center, Bronx, New York, USA.
ORCID-Profile: Sanghamitra Mohanty, Luigi DiBiase, Dhanunjaya Lakkireddy
Zitieren
APA
Katapadi, A., Patel, K., Chelikam, N., Arab, A., Herink, E., Spence, M. J., Kabra, R., Pothineni, N. V. K., Darden, D., Gopinathannair, R., Atkins, D., Bommana, S., Mohanty, S., DiBiase, L., Natale, A., & Lakkireddy, D. (2026). External Suture‐Retention Device Versus Manual Compression for Venous Access‐Site Closure Post‐Ablation: The LockeT II Study. Journal of Cardiovascular Electrophysiology, 37(8), 1723-1730. https://doi.org/10.1111/jce.70369
Vancouver
Katapadi A, Patel K, Chelikam N, Arab A, Herink E, Spence MJ, et al. External Suture‐Retention Device Versus Manual Compression for Venous Access‐Site Closure Post‐Ablation: The LockeT II Study. Journal of Cardiovascular Electrophysiology. 2026;37(8):1723-1730. doi:10.1111/jce.70369
BibTeX
@article{Katapadi2026,
author = {Katapadi, Aashish and Patel, Karnik and Chelikam, Nikhila and Arab, Ayesha and Herink, Eli and Spence, Madison J and Kabra, Rajesh and Pothineni, Naga Venkata K and Darden, Douglas and Gopinathannair, Rakesh and Atkins, Donita and Bommana, Sudha and Mohanty, Sanghamitra and DiBiase, Luigi and Natale, Andrea and Lakkireddy, Dhanunjaya},
title = {External Suture‐Retention Device Versus Manual Compression for Venous Access‐Site Closure Post‐Ablation: The LockeT II Study},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2026},
volume = {37},
number = {8},
pages = {1723--1730},
doi = {10.1111/jce.70369}
}
EUVIMED